Brian T. Carley - 30 Jun 2026 Form 4 Insider Report for Medpace Holdings, Inc. (MEDP)

Reporting relationship: Director
Issuer ticker: MEDP
Reported as of: 30 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jul 2026, 16:04:35 UTC
Prior SEC filing: 18 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Stephen P. Ewald, Attorney-in-Fact for Brian T. Carley

Key filing fact

Brian T. Carley filed Form 4 for Medpace Holdings, Inc. (MEDP) on 02 Jul 2026.

Key facts

This page summarizes Brian T. Carley's Form 4 filing for Medpace Holdings, Inc. (MEDP).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 02 Jul 2026, 16:04.

Change

Previous filing in this sequence was filed on 18 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001677791 Primary reporting owner

Carley Brian T

Relationship: Director
Address: C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI
Signature: /s/ Stephen P. Ewald, Attorney-in-Fact for Brian T. Carley
Signature date: 02 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MEDP transaction

Common Stock

Options Exercise

Transaction value
Shares: +36
Change %: +0.11%
Price
Shares after: 32,825
Date: 30 Jun 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MEDP transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares: -36
Change %: -34%
Price: $0.000000^*
Shares after: 71
Date: 30 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 36
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

Footnote F2

On November 28, 2025, the Reporting Person was granted 143 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026.